Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
Autor: | Claus Hélix-Nielsen |
---|---|
Rok vydání: | 2018 |
Předmět: |
separation
Computer science 02 engineering and technology Technology development Water Treatment Techniques lcsh:Chemical technology 01 natural sciences Biomimetic membrane Biomimetics Energy-conversion Chemical Engineering (miscellaneous) Energy transformation Water treatment lcsh:TP1-1185 lcsh:Chemical engineering sensing Controlled drug delivery Biomimetic processes Targeted drug delivery Aquaporin Photovoltaic cells lcsh:TP155-156 biomimetic 021001 nanoscience & nanotechnology Scalability Photoelectrochemical cells Biomimetic 0210 nano-technology Biotechnology Electric Batteries Biomimetic membranes Functional components Membrane technology biomedicine Filtration and Separation Technology platforms Mechanism of action 010402 general chemistry Aquaporins Chemical Operations Separation SDG 7 - Affordable and Clean Energy Energy Conversion Process Chemistry and Technology Production cost 0104 chemical sciences aquaporin Biomedicine energy-conversion Sensing Biochemical engineering |
Zdroj: | Membranes, Vol 8, Iss 3, p 44 (2018) Hélix-Nielsen, C 2018, ' Biomimetic membranes as a technology platform: Challenges and opportunities ', Membranes, vol. 8, no. 3, 44 . https://doi.org/10.3390/membranes8030044 |
ISSN: | 2077-0375 |
DOI: | 10.3390/membranes8030044 |
Popis: | Biomimetic membranes are attracting increased attention due to the huge potential of using biological functional components and processes as an inspirational basis for technology development. Indeed, this has led to several new membrane designs and applications. However, there are still a number of issues which need attention. Here, I will discuss three examples of biomimetic membrane developments within the areas of water treatment, energy conversion, and biomedicine with a focus on challenges and applicability. While the water treatment area has witnessed some progress in developing biomimetic membranes of which some are now commercially available, other areas are still far from being translated into technology. For energy conversion, there has been much focus on using bacteriorhodopsin proteins, but energy densities have so far not reached sufficient levels to be competitive with state-of-the-art photovoltaic cells. For biomedical (e.g., drug delivery) applications the research focus has been on the mechanism of action, and much less on the delivery ‘per se’. Thus, in order for these areas to move forward, we need to address some hard questions: is bacteriorhodopsin really the optimal light harvester to be used in energy conversion? And how do we ensure that biomedical nano-carriers covered with biomimetic membrane material ever reach their target cells/tissue in sufficient quantities? In addition to these area-specific questions the general issue of production cost and scalability must also be treated in order to ensure efficient translation of biomimetic membrane concepts into reality. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |